Kezar Life Sciences
CA - South SFBiotechnology
Focus: Kezar Life Sciences is a clinical-stage biotech focused on immunology therapies for autoimmune disorders, based in South San Francisco. The company is undergoing acquisition by Aurinia Pharmaceuticals as of April 2026.
Profile data last refreshed 6h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Kezar Life Sciences
AI assessmentNot HiringNo open roles listed right now. Follow Kezar Life Sciences to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
7 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
PHASE_1
Clinical Trials (1)
NCT05047536KZR-261 in Subjects With Advanced Solid Malignancies
Phase 1Help build intelligence for Kezar Life Sciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.